1 |
Chandrashekar J, Hoon MA, Ryba NJ, et al. The receptors and cells for mammalian taste[J]. Nature, 2006, 444(7117): 288-294.
|
2 |
Walliczek-Dworschak U, Schöps F, Feron G, et al. Differences in the density of fungiform papillae and composition of saliva in patients with taste disorders compared to healthy controls[J]. Chem Senses, 2017, 42(8): 699-708.
|
3 |
Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China[J]. JAMA Neurol, 2020, 77(6): 683-690.
|
4 |
Cowart BJ. Taste dysfunction: a practical guide for oral medicine[J]. Oral Dis, 2011, 17(1): 2-6.
|
5 |
Lee AA, Sugars Owyang C., sweet taste receptors, and responses brain[J]. Nutrients, 2017, 9(7): 653.
|
6 |
Zhu X, He L, McCluskey LP. Ingestion of bacterial lipopolysaccharide inhibits peripheral taste responses to sucrose in mice[J]. Neuroscience, 2014, 258: 47-61.
|
7 |
Lee Y, Rio DC. Mechanisms and regulation of alternative pre-mRNA splicing[J]. Annu Rev Biochem, 2015, 84: 291-323.
|
8 |
Lee FF, Davidson K, Harris C, et al. NF-κB mediates lipopolysaccharide-induced alternative pre-mRNA splicing of MyD88 in mouse macrophages[J]. J Biol Chem, 2020, 295(18): 6236-6248.
|
9 |
Nelson G, Hoon MA, Chandrashekar J, et al. Mammalian sweet taste receptors[J]. Cell, 2001, 106(3): 381-390.
|
10 |
Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome[J]. J Bacteriol, 2010, 192(19): 5002-5017.
|
11 |
Wade WG. The oral microbiome in health and disease[J]. Pharmacol Res, 2013, 69(1): 137-143.
|
12 |
Maldonado RF, Sá-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection[J]. FEMS Microbiol Rev, 2016, 40(4): 480-493.
|
13 |
Feng S, Achoute L, Margolskee RF, et al. Lipopolysaccharide-induced inflammatory cytokine expression in ta-ste organoids[J]. Chem Senses, 2020, 45(3): 187-194.
|
14 |
Urwyler S. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives[J]. Pharmacol Rev, 2011, 63(1): 59-126.
|
15 |
Kim HK, Pham MHC, Ko KS, et al. Alternative splicing isoforms in health and disease[J]. Pflugers Arch, 2018, 470(7): 995-1016.
|
16 |
Urbanski L, Leclair N, Anczuków O. Alternative-splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics[J]. Wiley Interdiscip Rev RNA, 2018, 9(4): e1476.
|